Table of Contents

October 2018; Volume 38,Issue 10

  1. Adelstein, DAVID J.

    1. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases
      VAMSI VARRA, NEIL M. WOODY, CHANDANA REDDY, NIKHIL P. JOSHI, JESSICA GEIGER, DAVID J. ADELSTEIN, BRIAN B. BURKEY, JOSEPH SCHARPF, BRANDON PRENDES, ERIC D. LAMARRE, ROBERT LORENZ, BRIAN GASTMAN, BINDU V. MANYAM and SHLOMO A. KOYFMAN
      Anticancer Research October 2018, 38 (10) 5825-5830; DOI: https://doi.org/10.21873/anticanres.12923

  2. Afroze, SYEDA H.

    1. Differential Effects of In Vitro Treatment with Cinobufotalin on Three Types of Ovarian Cancer Cells
      SYEDA H. AFROZE, CHANDER PEDDABOINA, ANTHONY B. MCDOWELL, A.H.M. ZUBERI ASHRAF, TIMOTHY C. MCCORMICK, M. KAREN NEWELL-ROGERS, DAVID C. ZAWIEJA, THOMAS J. KUEHL and MOHAMMAD N. UDDIN
      Anticancer Research October 2018, 38 (10) 5717-5724; DOI: https://doi.org/10.21873/anticanres.12909

  3. Ahn, JOONG HYUN

    1. Prominent Nucleoli and Non-glandular Feature Are Independent Predictors of PD-L1 Expression in Lung Adenocarcinoma
      NARA YOON, JIYOUNG KIM, LEE-SO MAENG, JOONG HYUN AHN and EUN SU PARK
      Anticancer Research October 2018, 38 (10) 6003-6008; DOI: https://doi.org/10.21873/anticanres.12949

  4. Aitken, KATHARINE

    1. Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre
      AVANI ATHAUDA, DAVID WATKINS, KABIR MOHAMMED, IAN CHAU, NAUREEN STARLING, SHEELA RAO, DIANA TAIT, KATHARINE AITKEN and DAVID CUNNINGHAM
      Anticancer Research October 2018, 38 (10) 5943-5949; DOI: https://doi.org/10.21873/anticanres.12940

  5. Akahori, DAISUKE

    1. Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms
      YUICHI OZAWA, KEIGO KODA, DAISUKE AKAHORI, TAKASHI MATSUI, HIROTSUGU HASEGAWA, TAKUYA KAKUTANI, TUSUKE AMANO, MASAYUKI TANAHASHI, HIROSHI NIWA, YUKIHIRO KUNIMOTO, KAZUNARI YAMADA, KOSHI YOKOMURA and TAKAFUMI SUDA
      Anticancer Research October 2018, 38 (10) 5937-5941; DOI: https://doi.org/10.21873/anticanres.12939

  6. Akamine, TAKAKI

    1. miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo
      TAKAKI AKAMINE, YOSUKE MORODOMI, YUI HARADA, KOJI TERAISHI, TETSUZO TAGAWA, TATSURO OKAMOTO, YOSHIHIKO MAEHARA and YOSHIKAZU YONEMITSU
      Anticancer Research October 2018, 38 (10) 5693-5701; DOI: https://doi.org/10.21873/anticanres.12906
    2. Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer
      SHINKICHI TAKAMORI, KAZUKI TAKADA, KOICHI AZUMA, YUMIKO JOGO, FUMIHIKO KINOSHITA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, TAKAKI AKAMINE, GOUJI TOYOKAWA, FUMIHIKO HIRAI, TETSUZO TAGAWA, ISAMU OKAMOTO, YOICHI NAKANISHI, AKIHIKO KAWAHARA, JUN AKIBA, YOSHINAO ODA and YOSHIHIKO MAEHARA
      Anticancer Research October 2018, 38 (10) 5903-5907; DOI: https://doi.org/10.21873/anticanres.12934

  7. Akiba, JUN

    1. Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer
      SHINKICHI TAKAMORI, KAZUKI TAKADA, KOICHI AZUMA, YUMIKO JOGO, FUMIHIKO KINOSHITA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, TAKAKI AKAMINE, GOUJI TOYOKAWA, FUMIHIKO HIRAI, TETSUZO TAGAWA, ISAMU OKAMOTO, YOICHI NAKANISHI, AKIHIKO KAWAHARA, JUN AKIBA, YOSHINAO ODA and YOSHIHIKO MAEHARA
      Anticancer Research October 2018, 38 (10) 5903-5907; DOI: https://doi.org/10.21873/anticanres.12934
    2. PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer
      SHINKICHI TAKAMORI, KAZUKI TAKADA, GOUJI TOYOKAWA, KOICHI AZUMA, MOTOTSUGU SHIMOKAWA, TOMOKO JOGO, YUICHI YAMADA, FUMIHIKO HIRAI, TETSUZO TAGAWA, AKIHIKO KAWAHARA, JUN AKIBA, ISAMU OKAMOTO, YOICHI NAKANISHI, YOSHINAO ODA, TOMOAKI HOSHINO and YOSHIHIKO MAEHARA
      Anticancer Research October 2018, 38 (10) 5897-5901; DOI: https://doi.org/10.21873/anticanres.12933

  8. Akiyama, HIROTOSHI

    1. A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
      YUSAKU TANAKA, CHIKARA KUNISAKI, YUSUKE IZUMISAWA, HIROCHIKA MAKINO, JUN KIMURA, SHO SATO, HIROSHI MIYAMOTO, TAKASHI KOSAKA, HIDETAKA A. ONO, MASAZUMI TAKAHASHI, KEI SATO, HIROTOSHI AKIYAMA and ITARU ENDO
      Anticancer Research October 2018, 38 (10) 6015-6021; DOI: https://doi.org/10.21873/anticanres.12951

  9. Alzahrani, NAYEF

    1. Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy
      BHAVNEET SINGH, GURKIRAT SINGH, MOHAMMAD POURGHOLAMI, NAYEF ALZAHRANI and DAVID L. MORRIS
      Anticancer Research October 2018, 38 (10) 5917-5921; DOI: https://doi.org/10.21873/anticanres.12936

  10. Amano, TUSUKE

    1. Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms
      YUICHI OZAWA, KEIGO KODA, DAISUKE AKAHORI, TAKASHI MATSUI, HIROTSUGU HASEGAWA, TAKUYA KAKUTANI, TUSUKE AMANO, MASAYUKI TANAHASHI, HIROSHI NIWA, YUKIHIRO KUNIMOTO, KAZUNARI YAMADA, KOSHI YOKOMURA and TAKAFUMI SUDA
      Anticancer Research October 2018, 38 (10) 5937-5941; DOI: https://doi.org/10.21873/anticanres.12939
« Previous (Pages : 1 2 3 4 5 6 ... 49) Next »
Back to top

In this issue